User login
- /content/inebilizumab-looks-good-neuromyelitis-optica-phase-2/3-trial
- /neurologyreviews/article/208143/multiple-sclerosis/inebilizumab-looks-good-neuromyelitis-optica
- /neurology/article/208143/multiple-sclerosis/inebilizumab-looks-good-neuromyelitis-optica-phase-2/3
- /clinicalneurologynews/article/208143/multiple-sclerosis/inebilizumab-looks-good-neuromyelitis-optica